Vedolizumab 108mg/0.68ml solution for injection pre-filled disposable devices
NHS hospitals in England used £108,676,650 of indicative cost of Vedolizumab 108mg/0.68ml solution for injection pre-filled disposable devices in the 12 months to April 2026, about 0.4% of all hospital medicines spend. That is up 18.7% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Vedolizumab 108mg/0.68ml solution for injection pre-filled disposable devices: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to April 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Vedolizumab 108mg/0.68ml solution for injection pre-filled disposable devices most
By indicative cost over the 12 months to April 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| Oxford University Hospitals Nhs Ft | £5,648,263 |
| Sheffield Teaching Hospitals Nhs Trust | £3,655,663 |
| University College London Foundation Tr | £3,325,613 |
| University Hospital Southampton Nhs Ft | £3,200,563 |
| Manchester University Nhs Ft | £2,829,000 |
| London North West Healthcare Nhs Trust | £2,815,163 |
| Gloucestershire Hpls Nhs Foundation Trst | £2,449,750 |
| The Newcastle Upon Tyne Hpl Nhs Found Tr | £2,424,125 |
| South Tees Hosp Nhs Foundation Trust | £2,388,250 |
| Western Sussex Hospitals Nhs Found Trust | £2,351,350 |
The primary-care picture
Vedolizumab is also dispensed in the community. See the national primary-care prescribing volume, cost and trend on the Vedolizumab medicine page.